Valeur Intrinsèque du S&P et Nasdaq Contactez-nous
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Retour aux actions

Greenwich LifeSciences, Inc. GLSI NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$50.00
+93%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Greenwich LifeSciences, Inc. (GLSI), dont 50 achats et 0 ventes. Le total des achats d'initiés s'élève à $24.19M et le total des ventes d'initiés à RSU Award.

Les initiés notables ayant une activité récente comprennent Patel Snehal, Mcwilliams David, Thompson Jaye. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — GLSI

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-01-13 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 1,800 $29.83 $53.69K 5,604,102
2026-01-12 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 2,900 $27.54 $79.87K 5,602,302
2025-12-31 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 4,300 $21.36 $91.85K 5,599,402
2025-12-30 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 2,900 $21.73 $63.02K 5,595,102
2025-12-18 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 4,100 $12.62 $51.74K 5,592,202
2025-11-25 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 4,600 $8.37 $38.5K 5,588,102
2025-11-13 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Attribution de RSU 100,000 $8.20 $820K 2,347,462
2025-11-07 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 10,600 $8.43 $89.36K 5,583,502
2025-10-31 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 2,300 $9.26 $21.3K 5,572,902
2025-04-25 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 3,600 $9.88 $35.57K 5,570,602
2025-04-17 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 5,400 $8.98 $48.49K 5,567,002
2025-04-07 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 3,600 $9.10 $32.76K 5,561,602
2025-04-04 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 5,500 $8.73 $48.02K 5,558,002
2025-01-10 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 2,500 $12.51 $31.28K 5,552,502
2025-01-07 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 1,800 $13.75 $24.75K 5,550,002
2025-01-06 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 1,100 $13.31 $14.64K 5,548,202
2025-01-03 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 3,400 $12.95 $44.03K 5,547,102
2025-01-02 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 2,000 $11.97 $23.94K 5,543,702
2024-12-31 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 2,400 $11.36 $27.26K 5,541,702
2024-12-30 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 3,200 $11.12 $35.58K 5,539,302
2024-12-24 Mcwilliams David Director Attribution de RSU 61,984 $12.16 $753.73K 123,968
2024-12-24 Thompson Jaye VP Clinical Reg Affairs Attribution de RSU 149,818 $12.16 $1.82M 299,636
2024-12-24 Daugherty Frank Joseph Chief Medical Officer Attribution de RSU 104,890 $12.16 $1.28M 209,780
2024-12-24 Rothe Eric Director Attribution de RSU 41,349 $12.16 $502.8K 82,698
2024-12-24 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Attribution de RSU 1,148,723 $12.16 $13.97M 2,222,454
2024-12-24 Hallock Kenneth Director Attribution de RSU 41,349 $12.16 $502.8K 82,698
2024-11-21 Thompson Jaye VP Clinical Reg Affairs Achat Informatif 1,000 $12.91 $12.91K 264,148
2024-09-26 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 1,500 $14.63 $21.95K 5,536,102
2024-08-12 Thompson Jaye VP Clinical Reg Affairs Achat Informatif 800 $13.85 $11.08K 263,148
2024-08-06 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 2,000 $13.81 $27.62K 5,534,602
2024-08-05 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 5,500 $13.18 $72.49K 5,532,602
2024-08-02 Thompson Jaye VP Clinical Reg Affairs Achat Informatif 1,000 $15.15 $15.15K 262,348
2024-07-23 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 1,500 $15.89 $23.84K 5,527,102
2024-07-18 Thompson Jaye VP Clinical Reg Affairs Achat Informatif 1,000 $16.00 $16K 261,348
2024-06-13 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 174,825 $14.30 $2.5M 5,525,602
2024-04-01 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 3,000 $19.08 $57.24K 5,350,777
2024-03-22 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 2,500 $19.98 $49.95K 5,347,777
2024-03-20 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 1,500 $17.68 $26.52K 5,345,277
2024-03-05 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 30,500 $12.49 $380.95K 5,343,777
2024-03-04 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 4,100 $13.03 $53.42K 5,340,277
2024-02-16 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 10,800 $11.16 $120.53K 5,336,177
2024-02-15 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 12,700 $11.07 $140.59K 5,325,377
2023-11-10 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 5,000 $10.17 $50.84K 5,312,677
2023-11-03 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 3,500 $9.11 $31.89K 5,307,677
2023-10-27 Thompson Jaye VP Clinical Reg Affairs Achat Informatif 500 $8.57 $4.29K 260,348
2023-10-26 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 2,500 $7.97 $19.93K 5,304,177
2023-10-25 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 2,500 $7.91 $19.78K 5,301,677
2023-10-10 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 1,000 $9.07 $9.07K 5,299,177
2023-10-04 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Achat Informatif 2,000 $8.63 $17.26K 5,298,177
2023-09-26 Thompson Jaye VP Clinical Reg Affairs Achat Informatif 600 $8.71 $5.23K 259,848
■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration

Les autres consultent aussi

TERN
TERN
Terns Pharmaceuticals, Inc.
$52.71
+0.06%
 DAWN
DAWN
Day One Biopharmaceuticals, Inc.
$21.47
+0.05%
 AMLX
AMLX
Amylyx Pharmaceuticals, Inc.
$17.12
+1.18%
 AVXL
AVXL
Anavex Life Sciences Corp.
$3.24
+3.85%
 INZY
INZY
Inozyme Pharma, Inc.
$4.00
+0.25%
 ABOS
ABOS
Acumen Pharmaceuticals, Inc.
$2.72
+1.49%
 IMMP
IMMP
Immutep Limited
$0.54
+72.81%
 PDSB
PDSB
PDS Biotechnology Corporation
$1.36
+28.30%
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
📧 [email protected]
📞 +65 8912 8000
Envoyez-nous un message